Literature DB >> 22359056

NR2B-containing NMDA receptors expression and their relationship to apoptosis in hippocampus of Alzheimer's disease-like rats.

Zhi'an Liu1, Chun'e Lv, Weiwei Zhao, Yuanjian Song, Dongsheng Pei, Tiejun Xu.   

Abstract

Although studies have shown that excitotoxicity mediated by N-methyl-D-aspartate receptors (NMDARs, NR) plays a prominent role in Alzheimer's disease (AD), the precise expression patterns of NMDARs and their relationship to apoptosis in AD have not been clearly established. In this study, we used Abeta (Aβ) 1-40 and AlCl(3) to establish AD rat model. The behavioral changes were detected by morris water maze and step-down test. The hippocampal amyloid deposition and pathological changes were determined by congo red and hematoxylin-eosin staining. Immunohistochemistry was used to detect expression of NR1, NR2A and NR2B, and TUNEL staining was used to detect apoptosis. Results showed that water maze testing escape latency of AD-like rats was prolonged significantly. Reaction time, basal number of errors, and number of errors of step-down test were increased significantly; latency period of step-down test was shortened significantly in AD-like rats. Amyloid substance deposition and obvious damage changes could be seen in hippocampus of AD-like rats. These results suggested that AD rat model could be successfully established by Aβ1-40 and AlCl(3). Results also showed that expression of NR1 and NR2B were significantly increased, but expression of NR2A had no significant change, in AD-like rat hippocampus. Meanwhile, apoptotic cells were significantly increased in AD-like rat hippocampus, especially in CA1 subfield and followed by dentate gyrus and CA3 subfield. These results implied that NR2B-, not NR2A-, containing NMDARs showed pathological high expression in AD-like rat hippocampus. This pathological high expression with apoptosis and selective vulnerability of hippocampus might be exist a specific relationship.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22359056     DOI: 10.1007/s11064-012-0726-0

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  34 in total

Review 1.  The NMDA receptor/ion channel complex: a drug target for modulating synaptic plasticity and excitotoxicity.

Authors:  Benedict C Albensi
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

2.  Neuropathological changes in brain cortex and hippocampus in a rat model of Alzheimer's disease.

Authors:  Maliheh Nobakht; Seyed Mohammad Hoseini; Pejman Mortazavi; Iraj Sohrabi; Banafshe Esmailzade; Nahid Rahbar Rooshandel; Shila Omidzahir
Journal:  Iran Biomed J       Date:  2011

Review 3.  Applications of the Morris water maze in the study of learning and memory.

Authors:  R D'Hooge; P P De Deyn
Journal:  Brain Res Brain Res Rev       Date:  2001-08

4.  Step-down-type passive avoidance- and escape-learning method. Suitability for experimental amnesia models.

Authors:  T Kameyama; T Nabeshima; T Kozawa
Journal:  J Pharmacol Methods       Date:  1986-08

Review 5.  Calcium dyshomeostasis and neurotoxicity of Alzheimer's beta-amyloid protein.

Authors:  Masahiro Kawahara; Midori Negishi-Kato; Yutaka Sadakane
Journal:  Expert Rev Neurother       Date:  2009-05       Impact factor: 4.618

6.  Hippocampal surface analysis in subjective memory impairment, mild cognitive impairment and Alzheimer's dementia.

Authors:  Ralf Tepest; Lei Wang; John G Csernansky; Philip Neubert; Reinhard Heun; Lukas Scheef; Frank Jessen
Journal:  Dement Geriatr Cogn Disord       Date:  2008-10-08       Impact factor: 2.959

Review 7.  Preventing Ca2+-mediated nitrosative stress in neurodegenerative diseases: possible pharmacological strategies.

Authors:  Tomohiro Nakamura; Stuart A Lipton
Journal:  Cell Calcium       Date:  2010-01-08       Impact factor: 6.817

8.  Aluminium exposure induces Alzheimer's disease-like histopathological alterations in mouse brain.

Authors:  L F Rodella; F Ricci; E Borsani; A Stacchiotti; E Foglio; G Favero; R Rezzani; C Mariani; R Bianchi
Journal:  Histol Histopathol       Date:  2008-04       Impact factor: 2.303

Review 9.  The Alzheimer's disease mitochondrial cascade hypothesis: an update.

Authors:  Russell H Swerdlow; Shaharyar M Khan
Journal:  Exp Neurol       Date:  2009-01-29       Impact factor: 5.330

Review 10.  A century of Alzheimer's disease.

Authors:  Michel Goedert; Maria Grazia Spillantini
Journal:  Science       Date:  2006-11-03       Impact factor: 47.728

View more
  16 in total

Review 1.  GluA2-dependent AMPA receptor endocytosis and the decay of early and late long-term potentiation: possible mechanisms for forgetting of short- and long-term memories.

Authors:  Oliver Hardt; Karim Nader; Yu-Tian Wang
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-12-02       Impact factor: 6.237

Review 2.  Multi-target design strategies in the context of Alzheimer's disease: acetylcholinesterase inhibition and NMDA receptor antagonism as the driving forces.

Authors:  Michela Rosini; Elena Simoni; Anna Minarini; Carlo Melchiorre
Journal:  Neurochem Res       Date:  2014-02-04       Impact factor: 3.996

Review 3.  Aberrant expression of RCAN1 in Alzheimer's pathogenesis: a new molecular mechanism and a novel drug target.

Authors:  Yili Wu; Philip T T Ly; Weihong Song
Journal:  Mol Neurobiol       Date:  2014-04-22       Impact factor: 5.590

4.  Design, synthesis, and in vitro and in vivo characterization of new memantine analogs for Alzheimer's disease.

Authors:  Andreea L Turcu; Júlia Companys-Alemany; Matthew B Phillips; Dhilon S Patel; Christian Griñán-Ferré; M Isabel Loza; José M Brea; Belén Pérez; David Soto; Francesc X Sureda; Maria G Kurnikova; Jon W Johnson; Mercè Pallàs; Santiago Vázquez
Journal:  Eur J Med Chem       Date:  2022-04-08       Impact factor: 7.088

5.  Enhancement of NMDA receptor-mediated excitatory postsynaptic currents by gp120-treated macrophages: implications for HIV-1-associated neuropathology.

Authors:  Jianming Yang; Dehui Hu; Jianxun Xia; Jianuo Liu; Gang Zhang; Howard E Gendelman; Nawal M Boukli; Huangui Xiong
Journal:  J Neuroimmune Pharmacol       Date:  2013-05-10       Impact factor: 4.147

6.  17α-Ethynyl-androst-5-ene-3β,7β,17β-triol (HE3286) Is Neuroprotective and Reduces Motor Impairment and Neuroinflammation in a Murine MPTP Model of Parkinson's Disease.

Authors:  Ferdinando Nicoletti; Ingrid Philippens; Paolo Fagone; Clarence N Ahlem; Christopher L Reading; James M Frincke; Dominick L Auci
Journal:  Parkinsons Dis       Date:  2012-09-26

7.  NetDiff - Bayesian model selection for differential gene regulatory network inference.

Authors:  Thomas Thorne
Journal:  Sci Rep       Date:  2016-12-16       Impact factor: 4.379

8.  Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, attenuates postoperative cognitive dysfunction in aging mice.

Authors:  Min Jia; Wen-Xue Liu; He-Liang Sun; Yan-Qing Chang; Jiao-Jiao Yang; Mu-Huo Ji; Jian-Jun Yang; Chen-Zhuo Feng
Journal:  Front Mol Neurosci       Date:  2015-09-23       Impact factor: 5.639

9.  NMDA reduces Tau phosphorylation in rat hippocampal slices by targeting NR2A receptors, GSK3β, and PKC activities.

Authors:  Audrée De Montigny; Ismaël Elhiri; Julie Allyson; Michel Cyr; Guy Massicotte
Journal:  Neural Plast       Date:  2013-11-20       Impact factor: 3.599

10.  Effects of Low Amyloid-β (Aβ) Concentration on Aβ1-42 Oligomers Binding and GluN2B Membrane Expression.

Authors:  Virginie Gilson; Corinne Mbebi-Liegeois; François Sellal; Jean de Barry
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.